References
- Ahn KC, Ma SJ, Tsai HJ, Gee SJ, Hammock BD. (2006). An immunoassay for a urinary metabolite as a biomarker of human exposure to the pyrethroid insecticide permethrin. Anal Bioanal Chem 384:713–722.
- Brusilow SW, Valle DL, Batshaw M. (1979). New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet 2:452–454.
- Devos A, Lino Cardenas CL, Glowacki F, Engels A, Lo-Guidice JM, Chevalier D, Allorge D, Broly F, Cauffiez C. (2010). Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation. Prostaglandins Leukot Essent Fatty Acids 83:105–110.
- Feoli-Fonseca JC, Lambert M, Mitchell G, Melançon SB, Dallaire L, Millington DS, Qureshi IA. (1996). Chronic sodium benzoate therapy in children with inborn errors of urea synthesis: effect on carnitine metabolism and ammonia nitrogen removal. Biochem Mol Med 57:31–36.
- Gatley SJ, Sherratt HS. (1977). The synthesis of hippurate from benzoate and glycine by rat liver mitochondria. Submitochondrial localization and kinetics. Biochem J 166:39–47.
- Hayashi K, Yandell DW. (1993). How sensitive is PCR-SSCP? Hum Mutat 2:338–346.
- James MO, Bend JR. (1978). Perinatal development of, and effect of chemical pretreatment on, glycine N-acyltransferase activities in liver and kidney of rabbit and rat. Biochem J 172:293–299.
- Kasuya F, Tatsuki T, Ohta M, Kawai Y, Igarashi K. (2006). Purification, characterization, and mass spectrometric sequencing of a medium chain acyl-CoA synthetase from mouse liver mitochondria and comparisons with the homologues of rat and bovine. Protein Expr Purif 47:405–414.
- Kelley M, Vessey DA. (1986). Interaction of 2,4-dichlorophenoxyacetate (2,4-D) and 2,4,5-trichlorophenoxyacetate (2,4,5-T) with the acyl-CoA: amino acid N-acyltransferase enzymes of bovine liver mitochondria. Biochem Pharmacol 35:289–295.
- Kelley M, Vessey DA. (1994). Characterization of the acyl-CoA:amino acid N-acyltransferases from primate liver mitochondria. J Biochem Toxicol 9:153–158.
- Killenberg PG, Davidson ED, Webster LT Jr. (1971). Evidence for a medium-chain fatty acid: coenzyme A ligase (adenosine monophosphate) that activates salicylate. Mol Pharmacol 7:260–268.
- Levy G. (1965). Pharmacokinetics of salicylate elimination in man. J Pharm Sci 54:959–967.
- Mawal Y, Paradis K, Qureshi IA. (1997). Developmental profile of mitochondrial glycine N-acyltransferase in human liver. J Pediatr 130:1003–1007.
- Meuldermans W, Hendrickx J, Lauwers W, Hurkmans R, Swysen E, Heykants J. (1986). Excretion and biotransformation of astemizole in rats, guinea-pigs, dogs, and man. Drug Development Research 8:37–51.
- Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766–2770.
- Quaranta S, Chevalier D, Allorge D, Lo-Guidice JM, Migot-Nabias F, Kenani A, Imbenotte M, Broly F, Lacarelle B, Lhermitte M. (2006). Ethnic differences in the distribution of CYP3A5 gene polymorphisms. Xenobiotica 36:1191–1200.
- Tremblay GC, Qureshi IA. (1993). The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen. Pharmacol Ther 60:63–90.
- Webster LT, Siddiqui UA, Lucas SV, Strong JM, Mieyal JJ. (1976). Identification of separate acyl- CoA:glycine and acyl-CoA:L-glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man. J Biol Chem 251:3352–3358.
- Yamamoto A, Nonen S, Fukuda T, Yamazaki H, Azuma J. (2009). Genetic polymorphisms of glycine N-acyltransferase in Japanese individuals. Drug Metab Pharmacokinet 24:114–117.